Synthesis and Biophysical Properties of Phosphorodiamidate Piperidino Oligomers. 2023

Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
School of Applied and Interdisciplinary Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India.

We report the synthesis of piperidino nucleoside phosphoramidates functionalized with uracil, cytosine, guanine, and adenine and their incorporation into oligomers. High-performance liquid chromatography analyses demonstrated that a phosphorodiamidate piperidino oligomer (PPO) is more lipophilic than a phosphorodiamidate morpholino oligomer (PMO) of the same tetrameric sequence. A PMO containing piperidino residues formed duplexes with both DNA and RNA, and the PPO had higher stability at endosomolytic pH and higher hydrophobicity than the PMO.

UI MeSH Term Description Entries
D016376 Oligonucleotides, Antisense Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. Anti-Sense Oligonucleotide,Antisense Oligonucleotide,Antisense Oligonucleotides,Anti-Sense Oligonucleotides,Anti Sense Oligonucleotide,Anti Sense Oligonucleotides,Oligonucleotide, Anti-Sense,Oligonucleotide, Antisense,Oligonucleotides, Anti-Sense
D060172 Morpholinos Synthetic analogs of NUCLEIC ACIDS composed of morpholine ring derivatives (MORPHOLINES) linked by phosphorodimidates. One standard DNA nucleic acid base (ADENINE; GUANINE; CYTOSINE; OR THYMINE) is bound to each morpholine ring. Morpholino,Morpholino Oligonucleotide,Phosphorodiamidate Morpholino Oligomer,MORF Oligomers,Morpholino Oligonucleotides,Morpholino Oligos,PMO Oligomers,Phosphorodiamidate Morpholino Oligomers,Morpholino Oligomer, Phosphorodiamidate,Morpholino Oligomers, Phosphorodiamidate,Oligomer, Phosphorodiamidate Morpholino,Oligomers, MORF,Oligomers, PMO,Oligomers, Phosphorodiamidate Morpholino,Oligonucleotide, Morpholino,Oligonucleotides, Morpholino,Oligos, Morpholino

Related Publications

Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
July 2021, Nature communications,
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
June 2001, Current opinion in molecular therapeutics,
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
October 2005, Current opinion in pharmacology,
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
September 2009, Current pharmaceutical biotechnology,
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
August 2019, Molecules (Basel, Switzerland),
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
January 2012, Methods in molecular biology (Clifton, N.J.),
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
January 1996, Antisense & nucleic acid drug development,
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
January 2018, Frontiers in microbiology,
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
December 2012, Antimicrobial agents and chemotherapy,
Atanu Ghosh, and Masaaki Akabane-Nakata, and Jayanta Kundu, and Joel M Harp, and Mimouna Madaoui, and Martin Egli, and Muthiah Manoharan, and Surajit Sinha
August 2000, Antisense & nucleic acid drug development,
Copied contents to your clipboard!